Forte Biosciences, Inc.
NASDAQ:FBRX
6.38 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -35.478 | -31.476 | -13.879 | -21.708 | -46.487 | -4.069 | -48.955 | -38.929 | -33.478 | -23.056 |
| Depreciation & Amortization
| 0.039 | 0.009 | 0 | 0.036 | 0.054 | 0.011 | 0.625 | 0.292 | 0.255 | 0.232 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0.918 | -6.87 | -4.451 | 0 | 0 |
| Stock Based Compensation
| 3.095 | 3.284 | 4.015 | 4.214 | 0.956 | 0.036 | 6.87 | 4.451 | 0 | 0 |
| Change In Working Capital
| 1.757 | -0.392 | 1.679 | 0.72 | -3.831 | 1.251 | 6.078 | 2.519 | 1.87 | 0.747 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 3.021 | 0.271 | 0.207 | -0.294 | -0.369 | 0.976 | 1.26 | 0.304 | 0.586 | 0.571 |
| Other Working Capital
| -1.264 | -0.663 | 1.472 | 1.014 | -3.462 | 0.275 | 4.818 | 2.215 | 1.284 | 0.176 |
| Other Non Cash Items
| -0.158 | -0.131 | 3.808 | 0.061 | 30.885 | -0.918 | 7.773 | 5.265 | 1.738 | 0.928 |
| Operating Cash Flow
| -30.745 | -28.706 | -8.185 | -16.677 | -18.423 | -2.771 | -34.469 | -31.133 | -29.539 | -21.042 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -0.037 | -0.088 | 0 | 0 | 0 | -0.162 | -1.968 | -0.655 | -0.525 | -0.231 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0.004 | 0 | 2.222 | 0.02 | 0 | 0.015 |
| Purchases Of Investments
| -35.956 | -9.965 | 0 | 0 | 0 | 0 | -70.746 | -70.797 | -23.003 | -59.87 |
| Sales Maturities Of Investments
| 0 | 10.1 | 0 | 0 | 0 | 0 | 68.524 | 43.725 | 48.095 | 35.158 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 3.578 | 42.319 | -2.222 | -27.052 | 25.092 | -24.697 |
| Investing Cash Flow
| -35.993 | 0.047 | 0 | 0 | 3.582 | -0.162 | -4.19 | -27.707 | 24.567 | -24.928 |
| Financing Activities: | ||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 23.325 | 0.138 | 2.914 | 50.741 |
| Common Stock Issued
| 53 | 24.744 | 7.229 | 0.062 | 66.699 | 4.856 | 28.845 | 89.125 | 0.01 | 0.157 |
| Common Stock Repurchased
| -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0.089 | 3.384 | 33.232 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -1.142 | -0.028 | 0.012 | -0.044 | -0.032 | 4.856 | -8.631 | 0 | -0.592 | -0.982 |
| Financing Cash Flow
| 51.857 | 24.684 | 7.241 | -0.044 | 66.667 | 4.856 | 43.539 | 89.263 | 2.332 | 49.916 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -14.881 | -3.975 | -0.944 | -16.721 | 51.826 | 1.923 | 4.88 | 30.423 | -2.64 | 3.946 |
| Cash At End Of Period
| 22.244 | 37.125 | 41.1 | 42.044 | 58.765 | 6.939 | 40.813 | 35.933 | 5.51 | 8.15 |